Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating ...

This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.

April 18, 2025 | Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to ahieve earlier diagnosis and intervention in valvular heart disease. Receive the the ...

Sunil Rao and Michelle O'Donoghue delve into the details.